Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


Daily Top 10 COVID-19 papers

DEU | ENG | ESP | FRA | ITA | POR | TUR | VNM


  Cervical Cancer, March 2020

Free Subscription


Abstracts

Retrieve all available abstracts of the following 228 articles:
HTML format


 

Single Articles

  1. THOMSEN LT, Kjaer SK, Munk C, Frederiksen K, et al
    Clinical Performance of Human Papillomavirus (HPV) Testing versus Cytology for Cervical Cancer Screening: Results of a Large Danish Implementation Study.
    Clin Epidemiol. 2020;12:203-213.
    PubMed    
    Abstract available

  2. DEREJE N, Addissie A, Worku A, Assefa M, et al
    Extent and Predictors of Delays in Diagnosis of Cervical Cancer in Addis Ababa, Ethiopia: A Population-Based Prospective Study.
    JCO Glob Oncol. 2020;6:277-284.
    PubMed    
    Abstract available

  3. COTANGCO K, Class QA, Johnson TP, Kothari R, et al
    Cervical cancer survivors' attitudes and understanding of menopause and hormone therapy.
    Menopause. 2020 Feb 24. doi: 10.1097/GME.0000000000001520.
    PubMed    
    Abstract available

  4. TOPUZ S, Kaban A, Kucucuk S, Salihoglu Y, et al
    Is Surgical Treatment an Option for Locally Advanced Cervical Cancer in the Presence of Central Residual Tumor after Chemoradiotherapy?
    Rev Bras Ginecol Obstet. 2020;42:35-42.
    PubMed    
    Abstract available

  5. GUO M, Lin B, Li G, Lin J, et al
    LncRNA TDRG1 promotes the proliferation, migration, and invasion of cervical cancer cells by sponging miR-214-5p to target SOX4.
    J Recept Signal Transduct Res. 2020.
    PubMed    
    Abstract available

  6. ZHU L, Zhang X, Sun Z
    SNRPB promotes cervical cancer progression through repressing p53 expression.
    Biomed Pharmacother. 2020;125:109948.
    PubMed    
    Abstract available

  7. YAN Z, Ruoyu L, Xing L, Hua L, et al
    Long non-coding RNA GAS5 regulates the growth and metastasis of human cervical cancer cells via induction of apoptosis and cell cycle arrest.
    Arch Biochem Biophys. 2020 Feb 24:108320. doi: 10.1016/j.abb.2020.108320.
    PubMed    
    Abstract available

  8. ABBAS KM, van Zandvoort K, Brisson M, Jit M, et al
    Effects of updated demography, disability weights, and cervical cancer burden on estimates of human papillomavirus vaccination impact at the global, regional, and national levels: a PRIME modelling study.
    Lancet Glob Health. 2020 Feb 24. pii: S2214-109X(20)30022.
    PubMed    
    Abstract available

  9. TOGAMI S, Kubo R, Kawamura T, Yanazume S, et al
    Comparison of lymphatic complications between sentinel node navigation surgery and pelvic lymphadenectomy in patients with cervical cancer.
    Jpn J Clin Oncol. 2020 Feb 27. pii: 5741667. doi: 10.1093.
    PubMed    
    Abstract available

  10. WANG T, Feng J, Zhang A
    miR-584 inhibits cell proliferation, migration and invasion in vitro and enhances the sensitivity to cisplatin in human cervical cancer by negatively targeting GLI1.
    Exp Ther Med. 2020;19:2059-2066.
    PubMed    
    Abstract available

  11. LIU C, Zhang Y, Liang S, Ying Y, et al
    Aldehyde dehydrogenase 1, a target of miR-222, is expressed at elevated levels in cervical cancer.
    Exp Ther Med. 2020;19:1673-1680.
    PubMed    
    Abstract available

  12. JATHO A, Bikaitwoha ME, Mugisha NM
    Socio-culturally mediated factors and lower level of education are the main influencers of functional cervical cancer literacy among women in Mayuge, Eastern Uganda.
    Ecancermedicalscience. 2020;14:1004.
    PubMed    
    Abstract available

  13. HASSAN RN, Luo H, Jiang W
    Effects of Nicotinamide on Cervical Cancer-Derived Fibroblasts: Evidence for Therapeutic Potential.
    Cancer Manag Res. 2020;12:1089-1100.
    PubMed    
    Abstract available

  14. TEKLE T, Wolka E, Nega B, Kumma WP, et al
    Knowledge, Attitude and Practice Towards Cervical Cancer Screening Among Women and Associated Factors in Hospitals of Wolaita Zone, Southern Ethiopia.
    Cancer Manag Res. 2020;12:993-1005.
    PubMed    
    Abstract available

  15. LIU F, Wen C
    LINC01410 Knockdown Suppresses Cervical Cancer Growth and Invasion via Targeting miR-2467-3p/VOPP1 Axis.
    Cancer Manag Res. 2020;12:855-861.
    PubMed    
    Abstract available

  16. WANG H, Wang MS, Zhou YH, Shi JP, et al
    Prognostic Values of LDH and CRP in Cervical Cancer.
    Onco Targets Ther. 2020;13:1255-1263.
    PubMed    
    Abstract available

  17. MA Z, Gu G, Pan W, Chen X, et al
    LncRNA PCAT6 Accelerates the Progression and Chemoresistance of Cervical Cancer Through Up-Regulating ZEB1 by Sponging miR-543.
    Onco Targets Ther. 2020;13:1159-1170.
    PubMed    
    Abstract available

  18. LU W, Wan X, Tao L, Wan J, et al
    Long Non-Coding RNA HULC Promotes Cervical Cancer Cell Proliferation, Migration and Invasion via miR-218/TPD52 Axis.
    Onco Targets Ther. 2020;13:1109-1118.
    PubMed    
    Abstract available

  19. TANG Q, Liu L, Zhang H, Xiao J, et al
    Regulations of miR-183-5p and Snail-Mediated Shikonin-Reduced Epithelial-Mesenchymal Transition in Cervical Cancer Cells.
    Drug Des Devel Ther. 2020;14:577-589.
    PubMed    
    Abstract available

  20. KEHOE S
    Radical hysterectomy for cervical cancer: reducing ureteric injuries.
    BJOG. 2020 Feb 27. doi: 10.1111/1471-0528.16181.
    PubMed    
    Abstract available

  21. HE Y, Xiao M, Fu H, Chen L, et al
    cPLA2alpha reversibly regulates different subsets of cancer stem cells transformation in cervical cancer.
    Stem Cells. 2020 Feb 26. doi: 10.1002/stem.3157.
    PubMed    
    Abstract available

  22. HE H, Pan Q, Pan J, Chen Y, et al
    Study on the correlation between hTREC and HPV load and cervical CINI/II/III lesions and cervical cancer.
    J Clin Lab Anal. 2020 Feb 26:e23257. doi: 10.1002/jcla.23257.
    PubMed    
    Abstract available

  23. YAMAMOTO T, Umezawa R, Tokunaga H, Kubozono M, et al
    Clinical experience of pelvic radiotherapy or chemoradiotherapy for postoperative uterine cervical cancer using intensity-modulated radiation therapy.
    J Radiat Res. 2020 Feb 26. pii: 5758151. doi: 10.1093.
    PubMed    
    Abstract available

  24. BUDERATH P, Kimmig R
    [Minimally invasive surgery for cervical cancer : Consequences of the LACC study].
    Urologe A. 2020 Feb 25. pii: 10.1007/s00120-020-01157.
    PubMed    


  25. ZHANG Y, Zhang X, Zhu H, Liu Y, et al
    Identification of Potential Prognostic Long Non-Coding RNA Biomarkers for Predicting Recurrence in Patients with Cervical Cancer.
    Cancer Manag Res. 2020;12:719-730.
    PubMed    
    Abstract available

  26. LIU X, Zhou Y, Ning YE, Gu H, et al
    MiR-195-5p Inhibits Malignant Progression of Cervical Cancer by Targeting YAP1.
    Onco Targets Ther. 2020;13:931-944.
    PubMed    
    Abstract available

  27. MA S, Liu C, Li B, Zhang T, et al
    Sonophoresis Enhanced Transdermal Delivery of Cisplatin in the Xenografted Tumor Model of Cervical Cancer.
    Onco Targets Ther. 2020;13:889-902.
    PubMed    
    Abstract available

  28. RANJIT S, Kodidela S, Sinha N, Chauhan S, et al
    Extracellular Vesicles from Human Papilloma Virus-Infected Cervical Cancer Cells Enhance HIV-1 Replication in Differentiated U1 Cell Line.
    Viruses. 2020;12.
    PubMed    
    Abstract available

  29. CEGLA P, Burchardt E, Cholewinski W, Gwozdz S, et al
    Comparison of semiquantitative metabolic parameters of the primary tumor obtained in PET/CT with 18F-FDG and 18F-FLT in patients with cervical cancer.
    Nuklearmedizin. 2020 Feb 25. doi: 10.1055/a-1084-4766.
    PubMed    
    Abstract available

  30. ALCAZAR JL, Garcia E, Machuca M, Quintana R, et al
    Magnetic resonance imaging and ultrasound for assessing parametrial infiltration in cervical cancer. A systematic review and meta-analysis.
    Med Ultrason. 2020;22:87-93.
    PubMed    
    Abstract available

  31. XIAO M, Ma F, Li Y, Li Y, et al
    Multiparametric MRI-Based Radiomics Nomogram for Predicting Lymph Node Metastasis in Early-Stage Cervical Cancer.
    J Magn Reson Imaging. 2020 Feb 25. doi: 10.1002/jmri.27101.
    PubMed    
    Abstract available

  32. JIANG N, Xie F, Chen L, Chen F, et al
    The effect of TLR4 on the growth and local inflammatory microenvironment of HPV-related cervical cancer in vivo.
    Infect Agent Cancer. 2020;15:12.
    PubMed    
    Abstract available

  33. CAMPOS-VIGURI GE, Peralta-Zaragoza O, Jimenez-Wences H, Longinos-Gonzalez AE, et al
    MiR-23b-3p reduces the proliferation, migration and invasion of cervical cancer cell lines via the reduction of c-Met expression.
    Sci Rep. 2020;10:3256.
    PubMed    
    Abstract available

  34. AFIYANTI Y, Setyowati, Milanti A, Young A, et al
    'Finally, I get to a climax': the experiences of sexual relationships after a psychosexual intervention for Indonesian cervical cancer survivors and the husbands.
    J Psychosoc Oncol. 2020 Feb 24:1-17. doi: 10.1080/07347332.2020.1720052.
    PubMed    
    Abstract available

  35. SUN YS, Thakur K, Hu F, Cespedes-Acuna CL, et al
    Icariside II suppresses cervical cancer cell migration through JNK modulated matrix metalloproteinase-2/9 inhibition in vitro and in vivo.
    Biomed Pharmacother. 2020;125:110013.
    PubMed    
    Abstract available

  36. SHARMA S, Deep A, Sharma AK
    Current Treatment for Cervical Cancer: An Update.
    Anticancer Agents Med Chem. 2020 Feb 23. pii: ACAMC-EPUB-104741.
    PubMed    
    Abstract available

  37. VORN R, Ryu E, Srun S, Chang S, et al
    Breast and cervical cancer screening for risk assessment in Cambodian women.
    J Obstet Gynaecol. 2020;40:395-400.
    PubMed    
    Abstract available

  38. GANGOPADHYAY A
    Prognostic Nutritional Index and Clinical Response in Locally Advanced Cervical Cancer.
    Nutr Cancer. 2020 Feb 24:1-5. doi: 10.1080/01635581.2020.1729820.
    PubMed    
    Abstract available

  39. FANG J, Zhang B, Wang S, Jin Y, et al
    Association of MRI-derived radiomic biomarker with disease-free survival in patients with early-stage cervical cancer.
    Theranostics. 2020;10:2284-2292.
    PubMed    
    Abstract available

  40. ESHETE M, Abdulwuhab Atta M, Yeshita HY
    Cervical Cancer Screening Acceptance among Women in Dabat District, Northwest Ethiopia, 2017: An Institution-Based Cross-Sectional Study.
    Obstet Gynecol Int. 2020;2020:2805936.
    PubMed    
    Abstract available

  41. CARBONNEL M, Dahm-Kahler P, Revaux A, Brannstrom M, et al
    Adapting surgical skills from robotic-assisted radical hysterectomy in cervical cancer to uterine transplantation: a look to an optimistic future!
    J Robot Surg. 2020 Feb 22. pii: 10.1007/s11701-020-01058.
    PubMed    
    Abstract available

  42. WANG AH, Jin CH, Cui GY, Li HY, et al
    MIR210HG promotes cell proliferation and invasion by regulating miR-503-5p/TRAF4 axis in cervical cancer.
    Aging (Albany NY). 2020;12.
    PubMed    
    Abstract available

  43. ARMENTANO B, Curcio R, Brindisi M, Mancuso R, et al
    5-(Carbamoylmethylene)-oxazolidin-2-ones as a Promising Class of Heterocycles Inducing Apoptosis Triggered by Increased ROS Levels and Mitochondrial Dysfunction in Breast and Cervical Cancer.
    Biomedicines. 2020;8.
    PubMed    
    Abstract available

  44. LIU J, Li S, Lin L, Jiang Y, et al
    Co-expression network analysis identified atypical chemokine receptor 1 (ACKR1) association with lymph node metastasis and prognosis in cervical cancer.
    Cancer Biomark. 2020;27:213-223.
    PubMed    
    Abstract available

  45. LIU Y, Li L, Li Y, Zhao X, et al
    Research Progress on Tumor-Associated Macrophages and Inflammation in Cervical Cancer.
    Biomed Res Int. 2020;2020:6842963.
    PubMed    
    Abstract available

  46. ERNSTSON A, Urdell A, Forslund O, Borgfeldt C, et al
    Cervical cancer prevention among long-term screening non-attendees by vaginal self-collected samples for hr-HPV mRNA detection.
    Infect Agent Cancer. 2020;15:10.
    PubMed    
    Abstract available

  47. DOU X, Zhou Q, Wen M, Xu J, et al
    Long Noncoding RNA FOXD2-AS1 Promotes the Malignancy of Cervical Cancer by Sponging MicroRNA-760 and Upregulating Hepatoma-Derived Growth Factor.
    Front Pharmacol. 2020;10:1700.
    PubMed    
    Abstract available


  48. [Expert consensus on immunological prevention of human papillomavirus-related diseases (abridged)].
    Zhonghua Liu Xing Bing Xue Za Zhi. 2019;40:1499-1516.
    PubMed    
    Abstract available

  49. KISSEL M, Rambeau A, Achkar S, Lecuru F, et al
    Challenges and advances in cervix cancer treatment in elder women.
    Cancer Treat Rev. 2020;84:101976.
    PubMed    
    Abstract available

  50. SANCHEZ-SILES M, Remezal-Solano M, Lopez-Lopez AM, Camacho-Alonso F, et al
    Prevalence of human papillomavirus in the saliva of sexually active women with cervical intraepithelial neoplasias.
    Med Oral Patol Oral Cir Bucal. 2020;25:e195-e204.
    PubMed    
    Abstract available

  51. LIU J, Ma S, Qin C, Zheng S, et al
    Prevalence and genotype distribution of human papillomavirus in Zhengzhou, China, in 2016.
    Arch Virol. 2020;165:731-736.
    PubMed    
    Abstract available

  52. MINUTOLI F, Pergolizzi S, Blandino A, Mormina E, et al
    Effect of granulocyte colony-stimulating factor on bone marrow: evaluation by intravoxel incoherent motion and dynamic contrast-enhanced magnetic resonance imaging.
    Radiol Med. 2020;125:280-287.
    PubMed    
    Abstract available

  53. GUTNIK H, Kastelic P, Ostrbenk Valencak A, Poljak M, et al
    Histomorphologic assessment and distribution of high-risk human papillomavirus (HPV) types in cervical high-grade squamous intraepithelial lesions with unusual histomorphologic features.
    Virchows Arch. 2020;476:251-260.
    PubMed    
    Abstract available

  54. FRANCIOSI JR, Gelmini GF, Roxo VS, de Carvalho NS, et al
    Is there a role played by HLA-E, if any, in HPV immune evasion?
    Scand J Immunol. 2020;91:e12850.
    PubMed    
    Abstract available

  55. XIE F, Zhang L, Zhao D, Wu X, et al
    Prior cervical cytology and high-risk HPV testing results for 311 patients with invasive cervical adenocarcinoma: a multicenter retrospective study from China's largest independent operator of pathology laboratories.
    BMC Infect Dis. 2019;19:962.
    PubMed    
    Abstract available

  56. GUPTA S, Giridhar P, Sharma D, K P H, et al
    Can Chemotherapy be Integrated with Brachytherapy in Locally Advanced Carcinoma Cervix- A Proof of Principle Study.
    Asian Pac J Cancer Prev. 2019;20:2653-2657.
    PubMed    
    Abstract available

  57. KARIMI-ZARCHI M, Moghimi M, Abbasi H, Hadadan A, et al
    Association of MTHFR 677C>T Polymorphism with Susceptibility to Ovarian and Cervical Cancers: A Systematic Review and Meta-Analysis.
    Asian Pac J Cancer Prev. 2019;20:2569-2577.
    PubMed    
    Abstract available

  58. VARGAS S, Valente MP, Almeida MM, Neves J, et al
    Isolated Non-16/18 High-Risk Human Papillomavirus Cervical Infection: Re-Evaluation After One Year.
    Acta Med Port. 2019;32:588-592.
    PubMed    
    Abstract available

  59. XU H, Pan H, Wang Y, Zhang J, et al
    Expanded study on the risk of lymphovascular space invasion and lymph node metastasis of endocervical adenocarcinoma using Pattern Classification: a single-centre analysis of 213 cases.
    Pathology. 2019;51:570-578.
    PubMed    
    Abstract available

  60. WANG XH, Li J
    CircAGFG1 aggravates the progression of cervical cancer by downregulating p53.
    Eur Rev Med Pharmacol Sci. 2020;24:1704-1711.
    PubMed    
    Abstract available

  61. LIU T, Kong W, Liu Y, Song D, et al
    Efficacy and prognostic factors of concurrent chemoradiotherapy in patients with stage Ib3 and IIa2 cervical cancer.
    Ginekol Pol. 2020;91:57-61.
    PubMed    
    Abstract available

  62. BADAJENA A, Raturi VP, Sirvastava K, Hojo H, et al
    Prospective evaluation of the setup errors and its impact on safety margin for cervical cancer pelvic conformal radiotherapy.
    Rep Pract Oncol Radiother. 2020;25:260-265.
    PubMed    
    Abstract available

  63. TANG Q, Chen Z, Zhao L
    Correction for: Circular RNA hsa_circ_0000515 acts as a miR-326 sponge to promote cervical cancer progression through up-regulation of ELK1.
    Aging (Albany NY). 2020;12:4040.
    PubMed    


  64. CHAICHIAN S, Moazzami B, Sadoughi F, Haddad Kashani H, et al
    Functional activities of beta-glucans in the prevention or treatment of cervical cancer.
    J Ovarian Res. 2020;13:24.
    PubMed    
    Abstract available

  65. CALYS-TAGOE BNL, Aheto JMK, Mensah G, Biritwum RB, et al
    Cervical cancer screening practices among women in Ghana: evidence from wave 2 of the WHO study on global AGEing and adult health.
    BMC Womens Health. 2020;20:49.
    PubMed    
    Abstract available

  66. GUTIERREZ-SILERIO GY, Franco-Topete RA, Haramati J, Navarrete-Medina EM, et al
    Positive staining of the immunoligand B7-H6 in abnormal/transformed keratinocytes consistently accompanies the progression of cervical cancer.
    BMC Immunol. 2020;21:9.
    PubMed    
    Abstract available

  67. WANG JD, Kong WM, Jiang H
    [FIGO 2018 staging of cervical cancer and related issues].
    Zhonghua Zhong Liu Za Zhi. 2020;42:94-98.
    PubMed    
    Abstract available

  68. SEBER S, Sirin DY, Yetisyigit T, Bilgen T, et al
    Piperlongumine increases the apoptotic effect of doxorubicin and paclitaxel in a cervical cancer cell line.
    Niger J Clin Pract. 2020;23:386-391.
    PubMed    
    Abstract available

  69. PASKETT ED, Pennell ML, Ruffin MT, Weghorst CM, et al
    A Multi-level Model to Understand Cervical Cancer Disparities in Appalachia.
    Cancer Prev Res (Phila). 2020;13:223-228.
    PubMed    
    Abstract available

  70. HUNG PS, Chuang FJ, Chen CY, Chou CH, et al
    miR-187* Enhances SiHa Cervical Cancer Cell Oncogenicity Via Suppression of WWOX.
    Anticancer Res. 2020;40:1427-1436.
    PubMed    
    Abstract available

  71. MEDEIROS R, Vaz S, Rebelo T, Figueiredo-Dias M, et al
    Prevention of Human Papillomavirus Infection. Beyond Cervical Cancer: A Brief Review.
    Acta Med Port. 2020;33:198-201.
    PubMed    
    Abstract available

  72. WU W, Guo L, Liang Z, Liu Y, et al
    Lnc-SNHG16/miR-128 axis modulates malignant phenotype through WNT/beta-catenin pathway in cervical cancer cells.
    J Cancer. 2020;11:2201-2212.
    PubMed    
    Abstract available

  73. CHEN G, Zhang M, Zhu J, Chen F, et al
    Common genetic variants in pre-microRNAs are associated with cervical cancer susceptibility in southern Chinese women.
    J Cancer. 2020;11:2133-2138.
    PubMed    
    Abstract available

  74. WANG K, Fan J, Lin W, Zou C, et al
    Functional polymorphism of PIN1 rs2233679 is associated with the progression of CIN to early cervical cancer in Hunan Chinese.
    Taiwan J Obstet Gynecol. 2020;59:220-226.
    PubMed    
    Abstract available

  75. ZHANG J, Wang L, Jiang J, Qiao Z, et al
    Elevation of microRNA-512-5p inhibits MUC1 to reduce radioresistance in cervical cancer.
    Cell Cycle. 2020 Mar 3:1-14. doi: 10.1080/15384101.2019.1711314.
    PubMed    
    Abstract available

  76. DOU Y, Huang D, Zeng X, Zhou Y, et al
    All-trans retinoic acid enhances the effect of Fra-1 to inhibit cell proliferation and metabolism in cervical cancer.
    Biotechnol Lett. 2020 Mar 2. pii: 10.1007/s10529-020-02847.
    PubMed    
    Abstract available

  77. TIAN W, Lei N, Guo R, Yuan Z, et al
    Long non-coding RNA DANCR promotes cervical cancer growth via activation of the Wnt/beta-catenin signaling pathway.
    Cancer Cell Int. 2020;20:61.
    PubMed    
    Abstract available

  78. MENG QH, Li Y, Kong C, Gao XM, et al
    Circ_0000388 Exerts Oncogenic Function in Cervical Cancer Cells by Regulating miR-337-3p/TCF12 Axis.
    Cancer Biother Radiopharm. 2020 Mar 2. doi: 10.1089/cbr.2019.3159.
    PubMed    
    Abstract available

  79. KLEIN C, Kahesa C, Mwaiselage J, West JT, et al
    How the Cervical Microbiota Contributes to Cervical Cancer Risk in Sub-Saharan Africa.
    Front Cell Infect Microbiol. 2020;10:23.
    PubMed    
    Abstract available

  80. TIAN X, Sun C, Liu Z, Li W, et al
    Prediction of Response to Preoperative Neoadjuvant Chemotherapy in Locally Advanced Cervical Cancer Using Multicenter CT-Based Radiomic Analysis.
    Front Oncol. 2020;10:77.
    PubMed    
    Abstract available

  81. DU Q, Wang W, Liu T, Shang C, et al
    High Expression of Integrin alpha3 Predicts Poor Prognosis and Promotes Tumor Metastasis and Angiogenesis by Activating the c-Src/Extracellular Signal-Regulated Protein Kinase/Focal Adhesion Kinase Signaling Pathway in Cervical Cancer.
    Front Oncol. 2020;10:36.
    PubMed    
    Abstract available

  82. GAO X, Jin Z, Tan X, Zhang C, et al
    Hyperbranched poly(beta-amino ester) based polyplex nanopaticles for delivery of CRISPR/Cas9 system and treatment of HPV infection associated cervical cancer.
    J Control Release. 2020 Feb 27. pii: S0168-3659(20)30135.
    PubMed    
    Abstract available

  83. HAO Y, Yan Z, Zhang A, Hu S, et al
    IL-6/STAT3 mediates the HPV18 E6/E7 stimulated upregulation of MALAT1 gene in cervical cancer HeLa cells.
    Virus Res. 2020 Feb 27:197907. doi: 10.1016/j.virusres.2020.197907.
    PubMed    
    Abstract available

  84. KADIAN L, Gulshan G, Sharma S, Kumari I, et al
    A Study on Knowledge and Awareness of Cervical Cancer Among Females of Rural and Urban Areas of Haryana, North India.
    J Cancer Educ. 2020 Feb 28. pii: 10.1007/s13187-020-01712.
    PubMed    
    Abstract available

  85. KIM S, Ryu KJ, Min KJ, Lee S, et al
    Learning curve for sentinel lymph node mapping in gynecologic malignancies.
    J Surg Oncol. 2020;121:599-604.
    PubMed    
    Abstract available

  86. YUCE TK, Ellis RJ, Chung J, Merkow RP, et al
    Association between surgical approach and survival following resection of abdominopelvic malignancies.
    J Surg Oncol. 2020;121:620-629.
    PubMed    
    Abstract available

  87. TRAN BX, Vo T, Dang AK, Nguyen QN, et al
    Knowledge towards Cervical and Breast Cancers among Industrial Workers: Results from a Multisite Study in Northern Vietnam.
    Int J Environ Res Public Health. 2019;16.
    PubMed    
    Abstract available

  88. GODFREY MAL, Mathenjwa S, Mayat N
    Rural Zulu women's knowledge of and attitudes towards Pap smears and adherence to cervical screening.
    Afr J Prim Health Care Fam Med. 2019;11:e1-e6.
    PubMed    
    Abstract available

  89. ZHU J, Wang H, Gao MJ, Li YF, et al
    Prognostic values of lymphocyte and eosinophil counts in resectable cervical squamous cell carcinoma.
    Future Oncol. 2019;15:3467-3481.
    PubMed    
    Abstract available

  90. LI S, Shen X, Xu QH, Cao Y, et al
    Gold nanorod enhanced conjugated polymer/photosensitizer composite nanoparticles for simultaneous two-photon excitation fluorescence imaging and photodynamic therapy.
    Nanoscale. 2019;11:19551-19560.
    PubMed    
    Abstract available

  91. TSAI YF, Chen TH, Yeh KT, Tsai HD, et al
    Complete non-puerperal uterine inversion caused by uterine hemangioma: A case report.
    Taiwan J Obstet Gynecol. 2019;58:688-691.
    PubMed    
    Abstract available

  92. FRANKLIN M, Webel A, Kaelber D, Evans J, et al
    Prevalence of Cervical Cancer Overscreening: Review of a Wellness Registry.
    Comput Inform Nurs. 2020 Mar 10. doi: 10.1097/CIN.0000000000000610.
    PubMed    
    Abstract available

  93. YAN L, Huang H, Zhang Y, Yuan X, et al
    Involvement of p53-dependent apoptosis signal in antitumor effect of Colchicine on human papilloma virus (HPV)positive human cervical cancer cells.
    Biosci Rep. 2020 Mar 12. pii: 222342. doi: 10.1042/BSR20194065.
    PubMed    
    Abstract available

  94. LIU X, Wang J, Hu K, Zhang F, et al
    Validation of the 2018 FIGO Staging System of Cervical Cancer for Stage III Patients with a Cohort from China.
    Cancer Manag Res. 2020;12:1405-1410.
    PubMed    
    Abstract available

  95. ZHAO D, Zhang H, Long J, Li M, et al
    LncRNA SNHG7 Functions as an Oncogene in Cervical Cancer by Sponging miR-485-5p to Modulate JUND Expression.
    Onco Targets Ther. 2020;13:1677-1689.
    PubMed    
    Abstract available

  96. WANG Q, Liu F, Wang L, Xie C, et al
    Enhanced and Prolonged Antitumor Effect of Salinomycin-Loaded Gelatinase-Responsive Nanoparticles via Targeted Drug Delivery and Inhibition of Cervical Cancer Stem Cells.
    Int J Nanomedicine. 2020;15:1283-1295.
    PubMed    
    Abstract available

  97. WANG J
    Combination Treatment of Cervical Cancer Using Folate-Decorated, pH-Sensitive, Carboplatin and Paclitaxel Co-Loaded Lipid-Polymer Hybrid Nanoparticles.
    Drug Des Devel Ther. 2020;14:823-832.
    PubMed    
    Abstract available

  98. OUK M, Edwards JD, Colby-Milley J, Kiss A, et al
    Psychiatric morbidity and cervical cancer screening: a retrospective population-based case-cohort study.
    CMAJ Open. 2020;8:E134-E141.
    PubMed    
    Abstract available

  99. QI W, Lv Q, Ma L, Tian W, et al
    Clinical Application of Folate Receptor-Mediated Staining Solution Detection in Cervical Cancer Screening.
    Ann Clin Lab Sci. 2020;50:73-78.
    PubMed    
    Abstract available

  100. SINGH N, Bhakuni R, Chhabria D, Kirubakaran S, et al
    MDC1 depletion promotes cisplatin induced cell death in cervical cancer cells.
    BMC Res Notes. 2020;13:146.
    PubMed    
    Abstract available

  101. DAI J, Wei R, Zhang P, Liu P, et al
    Long Noncoding RNA ZFPM2-AS1 Enhances the Malignancy of Cervical Cancer by Functioning as a Molecular Sponge of microRNA-511-3p and Consequently Increasing FGFR2 Expression.
    Cancer Manag Res. 2020;12:567-580.
    PubMed    
    Abstract available

  102. YANG H, Fang Z, Qu X, Zhang X, et al
    Procyanidin Compound (PC) Suppresses Lipopolysaccharide-Induced Cervical Cancer Cell Proliferation Through Blocking the TLR4/NF-kappaB Pathway.
    Cancer Manag Res. 2020;12:497-509.
    PubMed    
    Abstract available

  103. WU F, Sui Y, Wang Y, Xu T, et al
    Long Noncoding RNA SNHG7, a Molecular Sponge for microRNA-485, Promotes the Aggressive Behavior of Cervical Cancer by Regulating PAK4.
    Onco Targets Ther. 2020;13:685-699.
    PubMed    
    Abstract available

  104. TANGKA F, Kenny K, Miller J, Howard DH, et al
    The eligibility and reach of the national breast and cervical cancer early detection program after implementation of the affordable care act.
    Cancer Causes Control. 2020 Mar 10. pii: 10.1007/s10552-020-01286.
    PubMed    
    Abstract available

  105. HU Y, Hong Z, Gu L, Xie L, et al
    Evaluation of p16/Ki-67 Dual-stained Cytology in Triaging HPV-Positive Women During Cervical Cancer Screening.
    Cancer Epidemiol Biomarkers Prev. 2020 Mar 10. pii: 1055-9965.EPI-19-1180.
    PubMed    
    Abstract available

  106. TOMITA LY, Horta BL, da Silva LLS, Malta MB, et al
    Fruits and vegetables and cervical cancer: a systematic review and meta-analysis.
    Nutr Cancer. 2020 Mar 11:1-13. doi: 10.1080/01635581.2020.1737151.
    PubMed    
    Abstract available

  107. KIM MS, Lee EH, Park MI, Lee JS, et al
    Utility of Human Papillomavirus Testing for Cervical Cancer Screening in Korea.
    Int J Environ Res Public Health. 2020;17.
    PubMed    
    Abstract available

  108. CEJTIN HE, Schmidt JB
    Prevalence of Inadequate Cervical Cancer Screening in Low-Income Older Women.
    J Womens Health (Larchmt). 2020 Mar 9. doi: 10.1089/jwh.2019.8017.
    PubMed    
    Abstract available

  109. DE PREZ V, Jolidon V, Willems B, Cullati S, et al
    Cervical cancer (over)screening in Belgium and Switzerland: trends and social inequalities.
    Eur J Public Health. 2020 Mar 10. pii: 5802595. doi: 10.1093.
    PubMed    
    Abstract available

  110. TORNESELLO ML, Faraonio R, Buonaguro L, Annunziata C, et al
    The Role of microRNAs, Long Non-coding RNAs, and Circular RNAs in Cervical Cancer.
    Front Oncol. 2020;10:150.
    PubMed    
    Abstract available

  111. DIAZ-FEIJOO B, Torne A, Tejerizo A, Benito V, et al
    Prognostic Value and Therapeutic Implication of Laparoscopic Extraperitoneal Paraaortic Staging in Locally Advanced Cervical Cancer: A Spanish Multicenter Study.
    Ann Surg Oncol. 2020 Mar 9. pii: 10.1245/s10434-020-08329.
    PubMed    
    Abstract available

  112. MATSUMOTO Y, Mabuchi S, Isohashi F, Komura N, et al
    Impact of a reduction in follow-up frequency on life expectancy in uterine cervical cancer patients.
    Int J Clin Oncol. 2020 Mar 9. pii: 10.1007/s10147-020-01641.
    PubMed    
    Abstract available

  113. XU D, Dong P, Xiong Y, Yue J, et al
    MicroRNA-361-Mediated Inhibition of HSP90 Expression and EMT in Cervical Cancer Is Counteracted by Oncogenic lncRNA NEAT1.
    Cells. 2020;9.
    PubMed    
    Abstract available

  114. LEE J, Lin JB, Wu MH, Chang CL, et al
    Muscle Loss after Chemoradiotherapy as a Biomarker of Distant Failures in Locally Advanced Cervical Cancer.
    Cancers (Basel). 2020;12.
    PubMed    
    Abstract available

  115. CHERNIAK W, Tyler N, Arora K, Lapidos-Salaiz I, et al
    From potential to practice: how accelerating access to HPV tests and screen and treat programmes can help eliminate cervical cancer.
    Fam Med Community Health. 2019;7:e000182.
    PubMed    
    Abstract available

  116. XU C, Li X, Shi Y, Wang B, et al
    Combinative evaluation of primary tumor and lymph nodes to predict pelvic lymphatic metastasis in cervical cancer: an integrated PET-IVIM MRI study.
    Cancer Imaging. 2020;20:21.
    PubMed    
    Abstract available

  117. SANTOS ACDS, Silva NNT, Carneiro CM, Coura-Vital W, et al
    Knowledge about cervical cancer and HPV immunization dropout rate among Brazilian adolescent girls and their guardians.
    BMC Public Health. 2020;20:301.
    PubMed    
    Abstract available

  118. CHAMBUSO R, Ramesar R, Kaambo E, Murahwa AT, et al
    Age, absolute CD4 count, and CD4 percentage in relation to HPV infection and the stage of cervical disease in HIV-1-positive women.
    Medicine (Baltimore). 2020;99:e19273.
    PubMed    
    Abstract available

  119. TING CH, Lin KH, Chiu CH, Lee RC, et al
    Simultaneous Time-of-Flight PET/MR Identifies the Hepatic 90Y-Resin Distribution After Radioembolization.
    Clin Nucl Med. 2019 Dec 23. doi: 10.1097/RLU.0000000000002850.
    PubMed    
    Abstract available

  120. PATTYN J, Van Keer S, Teblick L, Van Damme P, et al
    HPV DNA detection in urine samples of women: 'an efficacious and accurate alternative to cervical samples?'
    Expert Rev Anti Infect Ther. 2019;17:755-757.
    PubMed    


  121. LIU L, Xue X, Xue L
    Liver metastatic basaloid squamous cell carcinoma with negative expression of pancytokeratin: a case report and literature review.
    Diagn Pathol. 2019;14:102.
    PubMed    
    Abstract available

  122. LIU X, Xie S, Zhang J, Kang Y, et al
    Long Noncoding RNA XIST Contributes to Cervical Cancer Development Through Targeting miR-889-3p/SIX1 Axis.
    Cancer Biother Radiopharm. 2020 Mar 19. doi: 10.1089/cbr.2019.3318.
    PubMed    
    Abstract available

  123. ILEVBARE OE, Adegoke AA, Adelowo CM
    Drivers of cervical cancer screening uptake in Ibadan, Nigeria.
    Heliyon. 2020;6:e03505.
    PubMed    
    Abstract available

  124. PARRA S, Carranza E, Coole J, Hunt B, et al
    Development of Low-Cost Point-of-Care Technologies for Cervical Cancer Prevention Based on a Single-Board Computer.
    IEEE J Transl Eng Health Med. 2020;8:4300210.
    PubMed    
    Abstract available

  125. LIU CH, Huang ZH, Dong XY, Zhang XQ, et al
    Inhibition of Uncoupling Protein 2 Enhances the Radiosensitivity of Cervical Cancer Cells by Promoting the Production of Reactive Oxygen Species.
    Oxid Med Cell Longev. 2020;2020:5135893.
    PubMed    
    Abstract available

  126. BILTEKIN F, Gultekin M, Yilmaz MT, Yildiz F, et al
    Dosimetric comparison of two different applicators and rectal retraction methods used in inverse optimization-based intracavitary brachytherapy for cervical cancer.
    J Contemp Brachytherapy. 2020;12:35-43.
    PubMed    
    Abstract available

  127. CROSSLEY N, Tipton C, Meier T, Sudhoff M, et al
    The value of hybrid interstitial tandem and ring applicators for organ at risk dose reduction in small volume cervical cancer.
    J Contemp Brachytherapy. 2020;12:12-16.
    PubMed    
    Abstract available

  128. LONG M, Lin F, Wang X, Chen X, et al
    Adenovirus-mediated anti-AEG-1 ScFv expression driven by stathmin promoter inhibits tumor growth in cervical cancer.
    Cancer Cell Int. 2020;20:79.
    PubMed    
    Abstract available

  129. DYKENS JA, Smith JS, Demment M, Marshall E, et al
    Evaluating the implementation of cervical cancer screening programs in low-resource settings globally: a systematized review.
    Cancer Causes Control. 2020 Mar 17. pii: 10.1007/s10552-020-01290.
    PubMed    
    Abstract available

  130. WANG L, Liang TT
    CD59 receptor targeted delivery of miRNA-1284 and cisplatin-loaded liposomes for effective therapeutic efficacy against cervical cancer cells.
    AMB Express. 2020;10:54.
    PubMed    
    Abstract available

  131. LIU C, Cui R, Li M, Feng Y, et al
    The Safety and Efficacy of Intra-Arterial versus Intravenous Neoadjuvant Chemotherapy in Patients with Locally Advanced Cervical Cancer: A Meta-Analysis.
    Evid Based Complement Alternat Med. 2020;2020:5023405.
    PubMed    
    Abstract available

  132. GANG X, Yuan M, Zhang J
    Long Non-Coding RNA TMPO-AS1 Promotes Cervical Cancer Cell Proliferation, Migration, and Invasion by Regulating miR-143-3p/ZEB1 Axis.
    Cancer Manag Res. 2020;12:1587-1599.
    PubMed    
    Abstract available


  133. Erratum: SMAGP a Novel Biomarker of Cervical Cancer Development and Progression [Erratum].
    Onco Targets Ther. 2020;13:1907-1908.
    PubMed    
    Abstract available

  134. ZHU Y, Jiang X, Zhang S, Wang L, et al
    Hsa_circ_103973 Acts as a Sponge of miR-335 to Promote Cervical Cancer Progression.
    Onco Targets Ther. 2020;13:1777-1786.
    PubMed    
    Abstract available

  135. SALEH M, Virarkar M, Javadi S, Elsherif SB, et al
    Cervical Cancer: 2018 Revised International Federation of Gynecology and Obstetrics Staging System and the Role of Imaging.
    AJR Am J Roentgenol. 2020 Mar 17:1-14. doi: 10.2214/AJR.19.21819.
    PubMed    
    Abstract available

  136. YANG HJ, Xue JM, Li J, Wan LH, et al
    Identification of key genes and pathways of diagnosis and prognosis in cervical cancer by bioinformatics analysis.
    Mol Genet Genomic Med. 2020 Mar 17:e1200. doi: 10.1002/mgg3.1200.
    PubMed    
    Abstract available

  137. MINNAAR CA, Kotzen JA, Naidoo T, Tunmer M, et al
    Analysis of the effects of mEHT on the treatment-related toxicity and quality of life of HIV-positive cervical cancer patients.
    Int J Hyperthermia. 2020;37:263-272.
    PubMed    
    Abstract available

  138. LI Z, Wu H, Yi X, Tian F, et al
    Area-specific economic status should be regarded as a vital factor affecting the occurrence, development and outcome of cervical cancer.
    Sci Rep. 2020;10:4759.
    PubMed    
    Abstract available

  139. PEETERS E, Cornet K, Devroey D, Arbyn M, et al
    Efficacy of strategies to increase participation in cervical cancer screening: GPs offering self-sampling kits for HPV testing versus recommendations to have a pap smear taken - A randomised controlled trial.
    Papillomavirus Res. 2020 Mar 13:100194. doi: 10.1016/j.pvr.2020.100194.
    PubMed    


  140. ARAYA LT, Fenta TG, Sander B, Gebremariam GT, et al
    Health-related quality of life and associated factors among cervical cancer patients at Tikur Anbessa specialized hospital, Addis Ababa, Ethiopia.
    Health Qual Life Outcomes. 2020;18:72.
    PubMed    
    Abstract available

  141. PERRONE AM, Dondi G, Coe M, Ferioli M, et al
    Predictive Role of MRI and (18)F FDG PET Response to Concurrent Chemoradiation in T2b Cervical Cancer on Clinical Outcome: A Retrospective Single Center Study.
    Cancers (Basel). 2020;12.
    PubMed    
    Abstract available

  142. HU S, Pu D, Xia X, Guo B, et al
    CTLA-4 rs5742909 polymorphism and cervical cancer risk: A meta-analysis.
    Medicine (Baltimore). 2020;99:e19433.
    PubMed    
    Abstract available

  143. GUO Q, Sun Y, Kong E, Rao L, et al
    Apatinib combined with chemotherapy or concurrent chemo-brachytherapy in patients with recurrent or advanced cervical cancer: A phase 2, randomized controlled, prospective study.
    Medicine (Baltimore). 2020;99:e19372.
    PubMed    
    Abstract available

  144. YANG LP, Feng HQ, Ma JC, Wu H, et al
    SIRT2 expression exhibits potential to serve as a biomarker for disease surveillance and prognosis in the management of cervical cancer patients.
    Medicine (Baltimore). 2020;99:e18668.
    PubMed    
    Abstract available

  145. VIDHUBALA E, Niraimathi K, Shewade HD, Mahadevan S, et al
    Cervical Cancer Care Continuum in South India: Evidence from a Community-based Screening Program.
    J Epidemiol Glob Health. 2020;10:28-35.
    PubMed    
    Abstract available

  146. SUN YH, Chou YH, Ou CC, Ng SC, et al
    Investigation of metastasis-associated in colon cancer-1 genetic variants in the development and clinicopathologcial characteristics of uterine cervical cancer in Taiwanese women.
    Int J Med Sci. 2020;17:490-497.
    PubMed    
    Abstract available

  147. MIKOSHIBA A, Minagawa A, Okuyama R
    Eosinophilic pustular folliculitis on the vulva of a patient with cervical cancer.
    J Dermatol. 2020 Mar 15. doi: 10.1111/1346-8138.15319.
    PubMed    


  148. CAI H, Yan L, Liu N, Xu M, et al
    Corrigendum to "IFI16 promotes cervical cancer progression by upregulating PD-L1 in immunomicroenvironment through STING-TBK1-NF-kB pathway" [Biomed. Pharmacother. 123 (2020) 109790].
    Biomed Pharmacother. 2020 Mar 12:110077. doi: 10.1016/j.biopha.2020.110077.
    PubMed    


  149. VAN DEN HELDER R, van Trommel NE, van Splunter AP, Lissenberg-Witte BI, et al
    Methylation analysis in urine fractions for optimal Cin3 and cervical cancer detection.
    Papillomavirus Res. 2020 Mar 11:100193. doi: 10.1016/j.pvr.2020.100193.
    PubMed    
    Abstract available

  150. PFAFFENZELLER MS, Franciosi MLM, Cardoso AM
    Purinergic signaling and tumor microenvironment in cervical Cancer.
    Purinergic Signal. 2020 Mar 13. pii: 10.1007/s11302-020-09693.
    PubMed    
    Abstract available

  151. ZHANG Y, Li S, Ma XT, He XW, et al
    Carbon dots-embedded epitope imprinted polymer for targeted fluorescence imaging of cervical cancer via recognition of epidermal growth factor receptor.
    Mikrochim Acta. 2020;187:228.
    PubMed    
    Abstract available

  152. SHAH UJ, Nasiruddin M, Dar SA, Alam Khan MK, et al
    Emerging biomarkers and clinical significance of HPV genotyping in prevention and management of cervical cancer.
    Microb Pathog. 2020 Mar 10:104131. doi: 10.1016/j.micpath.2020.104131.
    PubMed    
    Abstract available

  153. FROHLICH G, Geszti G, Vizkeleti J, Agoston P, et al
    Dosimetric comparison of inverse optimisation methods versus forward optimisation in HDR brachytherapy of breast, cervical and prostate cancer.
    Strahlenther Onkol. 2019;195:991-1000.
    PubMed    
    Abstract available


  154. Adopting self-care interventions for sexual and reproductive health in the Eastern Mediterranean Region.
    East Mediterr Health J. 2019;25:441-442.
    PubMed    


  155. RAEI M, Schmid V, Moayyed M, Mahaki B, et al
    Spatio-temporal pattern of two common cancers among Iranian women: An adaptive smoothing model.
    J BUON. 2019;24:1268-1275.
    PubMed    
    Abstract available

  156. XU Y, Zhu L, Zhu L, Wang H, et al
    Strain elastography as an early predictor of long-term prognosis in patients with locally advanced cervical cancers treated with concurrent chemoradiotherapy.
    Eur Radiol. 2020;30:471-481.
    PubMed    
    Abstract available

  157. GOILLOT V, Pate M, Delaitre A, Akladios C, et al
    [Use of HPV virologic test for atypical glandular cells in Alsace between 2014 and 2016].
    Gynecol Obstet Fertil Senol. 2019;47:802-807.
    PubMed    
    Abstract available

  158. KORNIDES M, Head KJ, Feemster K, Zimet GD, et al
    Associations between HPV vaccination among women and their 11-14-year-old children.
    Hum Vaccin Immunother. 2019;15.
    PubMed    
    Abstract available

  159. KIM H, Park W, Cho WK
    Who can benefit from a lymph node boost in definitive chemoradiotherapy for node-positive cervical cancer: an evaluation of nodal failure in patients without nodal boost.
    J Radiat Res. 2020 Mar 25. pii: 5811552. doi: 10.1093.
    PubMed    
    Abstract available

  160. REICHHELD A, Mukherjee PK, Rahman SM, David KV, et al
    Prevalence of Cervical Cancer Screening and Awareness among Women in an Urban Community in South India-A Cross Sectional Study.
    Ann Glob Health. 2020;86:30.
    PubMed    
    Abstract available

  161. MAREE JE, Holtslander L, Maree JE
    The Experiences of Women Living With Cervical Cancer in Africa: A Metasynthesis of Qualitative Studies.
    Cancer Nurs. 2020 Mar 24. doi: 10.1097/NCC.0000000000000812.
    PubMed    
    Abstract available

  162. DYER C
    Irish Supreme Court upholds win for woman whose cervical cancer was missed.
    BMJ. 2020;368:m1196.
    PubMed    


  163. COLACURCI N, Schettino MT, Grimaldi V, De Luca FP, et al
    Flow cytometry characterization of pluripotent transmembrane glycoproteins on resident cervix uteri cells in patients screened for cervical cancer.
    Cancer Invest. 2020 Mar 24:1-23. doi: 10.1080/07357907.2020.1742349.
    PubMed    
    Abstract available

  164. YANG T, Xia S
    Study of the biological function of LncRNA LUCAT1 on cervical cancer cells by targeting miR-199b-5p.
    Biosci Rep. 2020 Mar 24. pii: 222453. doi: 10.1042/BSR20200422.
    PubMed    
    Abstract available

  165. XIA Y, Deng Y, Zhou Y, Li D, et al
    TSPAN31 suppresses cell proliferation in human cervical cancer through down-regulation of its antisense pairing with CDK4.
    Cell Biochem Funct. 2020 Mar 23. doi: 10.1002/cbf.3526.
    PubMed    
    Abstract available

  166. KONG TW, Kim M, Kim YH, Kim YB, et al
    High-risk human papillomavirus testing as a primary screening for cervical cancer: position statement by the Korean Society of Obstetrics and Gynecology and the Korean Society of Gynecologic Oncology.
    Obstet Gynecol Sci. 2020;63:107.
    PubMed    
    Abstract available

  167. HU X, Lu E, Pan C, Xu Y, et al
    Overexpression and biological function of PRDX6 in human cervical cancer.
    J Cancer. 2020;11:2390-2400.
    PubMed    
    Abstract available

  168. WU F, Zhang Y, Fang Y, Ma S, et al
    Elevated Expression of Inhibitor of Apoptosis-stimulating Protein of p53 (iASPP) and Methyltransferase-like 3 (METTL3) Correlate with Poor Prognosis in FIGO Ib1-IIa Squamous Cell Cervical Cancer.
    J Cancer. 2020;11:2382-2389.
    PubMed    
    Abstract available

  169. ZHANG Y, Sun S, Ding J, Hua K, et al
    The Effect of Different Surgical Methods on Female and Male Sexual Activity and Marital Quality in Patients With Early-Stage Cervical Cancer.
    Sex Med. 2020 Mar 19. pii: S2050-1161(20)30024.
    PubMed    
    Abstract available

  170. LITVIAKOV NV, Ibragimova MK, Tsyganov MM, Shpileva OV, et al
    Changes in the genetic landscape during the malignization of high grade squamous intraepithelial lesion into cervical cancer.
    Curr Probl Cancer. 2020 Mar 17:100567.
    PubMed    
    Abstract available

  171. MACCHIA G, Cerrotta A, Deodato F, Pappalardi B, et al
    Cervical cancer patterns of care in Italy: A radiation oncology survey of MITO and AIRO GYN groups.
    Crit Rev Oncol Hematol. 2020;149:102925.
    PubMed    
    Abstract available

  172. HE Y, Li XM, Yin CH, Wu YM, et al
    Killing cervical cancer cells by specific chimeric antigen receptor-modified T cells.
    J Reprod Immunol. 2020;139:103115.
    PubMed    
    Abstract available

  173. ZHANG L, Liu F, Fu Y, Chen X, et al
    MiR-520d-5p functions as a tumor-suppressor gene in cervical cancer through targeting PTK2.
    Life Sci. 2020 Mar 17:117558. doi: 10.1016/j.lfs.2020.117558.
    PubMed    
    Abstract available

  174. DING S, Huang X, Zhu J, Xu B, et al
    ADH7, miR-3065 and LINC01133 are associated with cervical cancer progression in different age groups.
    Oncol Lett. 2020;19:2326-2338.
    PubMed    
    Abstract available

  175. LU Y, Xu X, Nong XH, Yao DS, et al
    Detection of high-risk human papillomavirus DNA in sentinel lymph nodes of patients with cervical cancer.
    Oncol Lett. 2020;19:2317-2325.
    PubMed    
    Abstract available

  176. NAKAMURA M, Hayashi M, Konishi H, Nunode M, et al
    MicroRNA-22 enhances radiosensitivity in cervical cancer cell lines via direct inhibition of c-Myc binding protein, and the subsequent reduction in hTERT expression.
    Oncol Lett. 2020;19:2213-2222.
    PubMed    
    Abstract available

  177. OU R, Mo L, Tang H, Leng S, et al
    circRNA-AKT1 Sequesters miR-942-5p to Upregulate AKT1 and Promote Cervical Cancer Progression.
    Mol Ther Nucleic Acids. 2020;20:308-322.
    PubMed    
    Abstract available

  178. SHU P, Li R, Xie D, He Y, et al
    Clinical profile and treatment outcome of collision carcinoma in cervix.
    Medicine (Baltimore). 2020;99:e19131.
    PubMed    
    Abstract available

  179. CHEN J, He B, Dong D, Liu P, et al
    Noninvasive CT radiomic model for preoperative prediction of lymph node metastasis in early cervical carcinoma.
    Br J Radiol. 2020 Jan 20:20190558. doi: 10.1259/bjr.20190558.
    PubMed    
    Abstract available

  180. BI Y, Li L
    Pathologically confirmed brain metastases from primary uterine cervical tumors: two cases and a literature review.
    World J Surg Oncol. 2019;17:174.
    PubMed    
    Abstract available

  181. BOONLIKIT S, Arnont P
    Replacing Iodine Staining with Size of Lesion: The Performance of Modified Reid Colposcopic Index.
    Asian Pac J Cancer Prev. 2019;20:3021-3028.
    PubMed    
    Abstract available

  182. OGU CO, Achukwu PU, Nkwo PO
    Prevalence and Risk Factors of Cervical Dysplasia among Human Immunodeficiency Virus Sero-Positive Females on Highly Active Antiretroviral Therapy in Enugu, Southeastern, Nigeria.
    Asian Pac J Cancer Prev. 2019;20:2987-2994.
    PubMed    
    Abstract available

  183. WHEELER BS, Rositch AF, Poole C, Taylor SM, et al
    Patterns of incident genital human papillomavirus infection in women: A literature review and meta-analysis.
    Int J STD AIDS. 2019;30:1246-1256.
    PubMed    


  184. LI Y, Liu J, Gong L, Sun X, et al
    Combining HPV DNA load with p16/Ki-67 staining to detect cervical precancerous lesions and predict the progression of CIN1-2 lesions.
    Virol J. 2019;16:117.
    PubMed    
    Abstract available

  185. LI L, Ma S, Tan X, Zhong S, et al
    Surgical, Urinary, and Survival Outcomes of Nerve-sparing Versus Traditional Radical Hysterectomy: A Retrospective Cohort Study in China.
    Am J Clin Oncol. 2019;42:783-788.
    PubMed    
    Abstract available

  186. JENSEN PT, Schnack TH, Froding LP, Bjorn SF, et al
    Survival after a nationwide adoption of robotic minimally invasive surgery for early-stage cervical cancer - A population-based study.
    Eur J Cancer. 2020;128:47-56.
    PubMed    
    Abstract available

  187. ASTHANA S, Busa V, Labani S
    Oral contraceptives use and risk of cervical cancer-A systematic review & meta-analysis.
    Eur J Obstet Gynecol Reprod Biol. 2020;247:163-175.
    PubMed    
    Abstract available

  188. CHOI CH, Chung JY, Kang JH, Paik ES, et al
    Chemoradiotherapy response prediction model by proteomic expressional profiling in patients with locally advanced cervical cancer.
    Gynecol Oncol. 2020 Feb 24. pii: S0090-8258(20)30153.
    PubMed    
    Abstract available

  189. AVIKI EM, Chen L, Dessources K, Leitao MM Jr, et al
    Impact of hospital volume on surgical management and outcomes for early-stage cervical cancer.
    Gynecol Oncol. 2020 Feb 21. pii: S0090-8258(20)30165.
    PubMed    
    Abstract available

  190. KIM H, Cho WK, Kim YJ, Kim YS, et al
    Significance of the number of high-risk factors in patients with cervical cancer treated with radical hysterectomy and concurrent chemoradiotherapy.
    Gynecol Oncol. 2020 Mar 2. pii: S0090-8258(20)30177.
    PubMed    
    Abstract available

  191. SUN Z, Huang B, Liu C, Yang Y, et al
    Comparison of neoadjuvant treatments followed by radical surgery or chemoradiation on quality of life in patients with stage IB2-IIA cervical cancer.
    Gynecol Oncol. 2020 Mar 12. pii: S0090-8258(20)30092.
    PubMed    
    Abstract available

  192. MIGNOT F, Gouy S, Schernberg A, Bockel S, et al
    Comprehensive analysis of patient outcome after local recurrence of locally advanced cervical cancer treated with concomitant chemoradiation and image-guided adaptive brachytherapy.
    Gynecol Oncol. 2020 Mar 13. pii: S0090-8258(20)30222.
    PubMed    
    Abstract available

  193. HAMMER A, Demarco M, Campos N, Befano B, et al
    Study of the Risks of CIN3+ detection following multiple rounds of HPV testing: Results of the 15-year cervical cancer screening experience at Kaiser Permanente Northern California.
    Int J Cancer. 2020 Mar 6. doi: 10.1002/ijc.32950.
    PubMed    
    Abstract available

  194. PILLERON S, Cabasag CJ, Ferlay J, Bray F, et al
    Cervical cancer burden in Latin America and the Caribbean: Where are we?
    Int J Cancer. 2020 Mar 9. doi: 10.1002/ijc.32956.
    PubMed    
    Abstract available

  195. WANG X, Ding Y, Cai HY, You J, et al
    Effectiveness of modified complex decongestive physiotherapy for preventing lower extremity lymphedema after radical surgery for cervical cancer: a randomized controlled trial.
    Int J Gynecol Cancer. 2020 Feb 26. pii: ijgc-2019-000911.
    PubMed    
    Abstract available

  196. LOVERIX L, Salihi RR, Van Nieuwenhuysen E, Concin N, et al
    Para-aortic lymph node surgical staging in locally-advanced cervical cancer: comparison between robotic versus conventional laparoscopy.
    Int J Gynecol Cancer. 2020 Feb 19. pii: ijgc-2019-000961.
    PubMed    
    Abstract available

  197. GULTEKIN M, Ramirez PT, Broutet N, Hutubessy R, et al
    World Health Organization call for action to eliminate cervical cancer globally.
    Int J Gynecol Cancer. 2020 Mar 2. pii: ijgc-2020-001285.
    PubMed    


  198. GULTEKIN M, Morice P, Concin N, Querleu D, et al
    ESGO contribution to the WHO initiative on elimination of cervical cancer.
    Int J Gynecol Cancer. 2020 Mar 2. pii: ijgc-2020-001286.
    PubMed    


  199. CHASE D, Huang HQ, Monk BJ, Ramondetta LM, et al
    Patient-reported outcomes at discontinuation of anti-angiogenesis therapy in the randomized trial of chemotherapy with bevacizumab for advanced cervical cancer: an NRG Oncology Group study.
    Int J Gynecol Cancer. 2020 Feb 28. pii: ijgc-2019-000869.
    PubMed    
    Abstract available

  200. MUROFUSHI K, Yoshioka Y, Sumi M, Ishikawa H, et al
    Outcomes analysis of pre-brachytherapy MRI in patients with locally advanced cervical cancer.
    Int J Gynecol Cancer. 2020 Mar 11. pii: ijgc-2019-000925.
    PubMed    
    Abstract available

  201. ZHONG ML, Wang YN, Liang MR, Liu H, et al
    Consolidation chemotherapy in early-stage cervical cancer patients with lymph node metastasis after radical hysterectomy.
    Int J Gynecol Cancer. 2020 Mar 9. pii: ijgc-2019-000690.
    PubMed    
    Abstract available

  202. ALLDREDGE J, Leaf MC, Patel P, Coakley K, et al
    Prevalence and predictors of HIV screening in invasive cervical cancer: a 10 year cohort study.
    Int J Gynecol Cancer. 2020 Mar 9. pii: ijgc-2019-000909.
    PubMed    
    Abstract available

  203. LAZZARI R, Riva G, Augugliaro M, Vavassori A, et al
    Intensity modulated radiation therapy boost in locally-advanced cervical cancer in the absence of brachytherapy.
    Int J Gynecol Cancer. 2020 Mar 17. pii: ijgc-2019-000735.
    PubMed    
    Abstract available

  204. MARGOLIS B, Cagle-Colon K, Chen L, Tergas AI, et al
    Prognostic significance of lymphovascular space invasion for stage IA1 and IA2 cervical cancer.
    Int J Gynecol Cancer. 2020 Mar 15. pii: ijgc-2019-000849.
    PubMed    
    Abstract available

  205. MELNIKOFF AK, Doo DW, Cohen AC, Landers E, et al
    Timing of robotic hysterectomy after cervical excisional procedure.
    Int J Gynecol Cancer. 2019;29:1110-1115.
    PubMed    
    Abstract available

  206. TREJO MJ, Lishimpi K, Kalima M, Mwaba CK, et al
    Effects of HIV status on non-metastatic cervical cancer progression among patients in Lusaka, Zambia.
    Int J Gynecol Cancer. 2020 Mar 21. pii: ijgc-2019-000987.
    PubMed    
    Abstract available

  207. MORO F, Gui B, Arciuolo D, Bertoldo V, et al
    Fusion imaging of ultrasound and MRI in the assessment of locally advanced cervical cancer: a prospective study.
    Int J Gynecol Cancer. 2020 Mar 18. pii: ijgc-2019-000902.
    PubMed    
    Abstract available

  208. HASAN Y, Furtado L, Tergas A, Lee N, et al
    A Phase I trial assessing the safety and tolerability of a therapeutic DNA vaccination against HPV16 and HPV18 E6/E7 oncogenes after chemoradiation for cervical cancer.
    Int J Radiat Oncol Biol Phys. 2020 Mar 6. pii: S0360-3016(20)30257.
    PubMed    
    Abstract available

  209. WANG Y, Master WH, Che S, Master YZ, et al
    Outcomes for hyperthermia combined with concurrent radiochemotherapy for patients with cervical cancer.
    Int J Radiat Oncol Biol Phys. 2020 Mar 13. pii: S0360-3016(20)30898.
    PubMed    
    Abstract available

  210. PERDRIZET J, D'Souza D, Skliarenko J, Ang M, et al
    A Cost-Utility Analysis of Magnetic Resonance (MR) Guided Brachytherapy versus Two Dimensional and Computed Tomography (CT) Guided Brachytherapy for Locally Advanced Cervical Cancer.
    Int J Radiat Oncol Biol Phys. 2020 Mar 10. pii: S0360-3016(20)30895.
    PubMed    
    Abstract available

  211. EINSTEIN MH
    Precision Screening for Posttreatment Surveillance.
    Obstet Gynecol. 2019;134:450-451.
    PubMed    


  212. BOTTARI F, Iacobone AD, Passerini R, Preti EP, et al
    Human Papillomavirus Genotyping Compared With a Qualitative High-Risk Human Papillomavirus Test After Treatment of High-Grade Cervical Intraepithelial Neoplasia: A Systematic Review.
    Obstet Gynecol. 2019;134:452-462.
    PubMed    
    Abstract available

  213. BREWER N, Bartholomew K, Maxwell A, Grant J, et al
    Correction to: Comparison of two invitation-based methods for human papillomavirus (HPV) self-sampling with usual care among un- and under-screened Maori, Pacific and Asian women: study protocol for a randomised controlled community trial to examine t
    BMC Cancer. 2020;20:163.
    PubMed    
    Abstract available

  214. EOH KJ, Lee JY, Nam EJ, Kim S, et al
    The institutional learning curve is associated with survival outcomes of robotic radical hysterectomy for early-stage cervical cancer-a retrospective study.
    BMC Cancer. 2020;20:152.
    PubMed    
    Abstract available

  215. YE S, Sun X, Kang B, Wu F, et al
    The kinetic profile and clinical implication of SCC-Ag in squamous cervical cancer patients undergoing radical hysterectomy using the Simoa assay: a prospective observational study.
    BMC Cancer. 2020;20:138.
    PubMed    
    Abstract available

  216. WANG H, Zhang D, Chen Q, Hong Y, et al
    Plasma expression of miRNA-21, - 214, -34a, and -200a in patients with persistent HPV infection and cervical lesions.
    BMC Cancer. 2019;19:986.
    PubMed    
    Abstract available

  217. LIU P, Lin L, Kong Y, Huo Z, et al
    Comparison of survival outcomes between radio-chemotherapy and radical hysterectomy with postoperative standard therapy in patients with stage IB1 to IIA2 cervical cancer: long-term oncological outcome analysis in 37 Chinese hospitals.
    BMC Cancer. 2020;20:189.
    PubMed    
    Abstract available

  218. WU Y, Ye S, Goswami S, Pei X, et al
    Clinical significance of peripheral blood and tumor tissue lymphocyte subsets in cervical cancer patients.
    BMC Cancer. 2020;20:173.
    PubMed    
    Abstract available

  219. MIKI Y, Tase T, Tokunaga H, Yaegashi N, et al
    Cervical cancer screening rates before and after the Great East Japan Earthquake in the Miyagi Prefecture, Japan.
    PLoS One. 2020;15:e0229924.
    PubMed    
    Abstract available

  220. KIM J, Jun SY
    Analytic performance of PANArray HPV and HPV 9G DNA chip tests for genotyping of high-risk human papillomavirus in cervical ThinPrep PreservCyt samples.
    PLoS One. 2019;14:e0224483.
    PubMed    
    Abstract available

  221. HUANG J, Luo JY, Tan HZ
    Associations of MGMT promoter hypermethylation with squamous intraepithelial lesion and cervical carcinoma: A meta-analysis.
    PLoS One. 2019;14:e0222772.
    PubMed    
    Abstract available

  222. SHUKLA S, Jadli M, Thakur K, Shishodia G, et al
    Level of phospho-STAT3 (Tyr705) correlates with copy number and physical state of human papillomavirus 16 genome in cervical precancer and cancer lesions.
    PLoS One. 2019;14:e0222089.
    PubMed    
    Abstract available

  223. OMORI M, Kondo T, Tagaya H, Watanabe Y, et al
    Utility of imaging modalities for predicting carcinogenesis in lobular endocervical glandular hyperplasia.
    PLoS One. 2019;14:e0221088.
    PubMed    
    Abstract available

  224. JAWOREK H, Kubanova K, Koudelakova V, Slavkovsky R, et al
    Pitfalls of commercially available HPV tests in HPV68a detection.
    PLoS One. 2019;14:e0220373.
    PubMed    
    Abstract available

  225. SETIAWAN D, Andrijono, Hadinegoro SR, Meyta H, et al
    Cervical cancer prevention in Indonesia: An updated clinical impact, cost-effectiveness and budget impact analysis.
    PLoS One. 2020;15:e0230359.
    PubMed    
    Abstract available

  226. TAYYAR Y, Shiels R, Bulmer AC, Lam AK, et al
    Development of an intravaginal ring for the topical delivery of Aurora kinase A inhibitor, MLN8237.
    PLoS One. 2019;14:e0225774.
    PubMed    
    Abstract available

  227. WESTRE B, Giske A, Guttormsen H, Wergeland Sorbye S, et al
    Quality control of cervical cytology using a 3-type HPV mRNA test increases screening program sensitivity of cervical intraepithelial neoplasia grade 2+ in young Norwegian women-A cohort study.
    PLoS One. 2019;14:e0221546.
    PubMed    
    Abstract available

  228. RAI SN, Srivastava S, Pan J, Wu X, et al
    Multi-group diagnostic classification of high-dimensional data using differential scanning calorimetry plasma thermograms.
    PLoS One. 2019;14:e0220765.
    PubMed    
    Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Cervical Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design:


;